Comparison of quality of life on nitrendipine and propranolol.

  title={Comparison of quality of life on nitrendipine and propranolol.},
  author={Prince K. Zachariah and R D Brobyn and J. Kann and Bernard L{\'e}vy and Robert Margolis and F. Gilbert McMahon and Russell C Reeves and D C Sperling and David Sweet and Philip G. Zager},
  journal={Journal of cardiovascular pharmacology},
  volume={12 Suppl 4},
A multicenter, randomized, double-blind, comparative study was conducted in 274 patients with mild to moderate hypertension to assess the impact of nitrendipine and propranolol on quality of life. After placebo baseline, 136 patients were given nitrendipine (5-20 mg b.i.d.) and 138 were given propranolol (40-120 mg b.i.d.). Quality of life was evaluated at baseline, weeks 6-10, and weeks 14-18 of the maintenance period. At weeks 6-10, the nitrendipine group became significantly more vigorous (p… CONTINUE READING